Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Beltran Lab
Explore this Website
Home
About Us
Toggle About Us menu options
Contact Us
Job Opportunities
Videos
Affiliations
Research
Lab Team
News
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Affiliations
Research
Lab Team
News
Publications
Home
Publications
Publications
Found 36 results
Author
Title
Type
Year
Filters:
First Letter Of Last Name
is
N
[Clear All Filters]
Journal Article
Beltran H
,
Park K
,
Tagawa ST
,
Macdonald T
,
Nanus DM
,
Mosquera JMiguel
,
Rubin MA
. 2012.
Association of concurrent AURKA and MYCN amplification in primary prostate adenocarcinoma with the development of lethal neuroendocrine prostate cancer (NEPC).
.
J Clin Oncol. 30(5_suppl):120.
Sailer V
,
Schiffman MH
,
Kossai M
,
Cyrta J
,
Beg S
,
Sullivan B
,
Pua BB
,
Lee KSteve
,
Talenfeld AD
,
Nanus DM
et al.
. 2017.
Bone biopsy protocol for advanced prostate cancer in the era of precision medicine.
.
Cancer.
Beltran H
,
Tagawa ST
,
Park K
,
MacDonald T
,
Milowsky MI
,
Mosquera JM
,
Rubin MA
,
Nanus DM
. 2012.
Challenges in recognizing treatment-related neuroendocrine prostate cancer.
.
J Clin Oncol. 30(36):386-9.
Beltran H
,
Tagawa ST
,
Park K
,
Macdonald T
,
Milowsky MI
,
Mosquera JMiguel
,
Rubin MA
,
Nanus DM
. 2012.
Challenges in recognizing treatment-related neuroendocrine prostate cancer.
.
J Clin Oncol. 30(36):e386-9.
Mateo J
,
Cheng HH
,
Beltran H
,
Dolling D
,
Xu W
,
Pritchard CC
,
Mossop H
,
Rescigno P
,
Perez-Lopez R
,
Sailer V
et al.
. 2018.
Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International Study.
.
Eur Urol.
Mateo J
,
Cheng HH
,
Beltran H
,
Dolling D
,
Xu W
,
Pritchard CC
,
Mossop H
,
Rescigno P
,
Perez-Lopez R
,
Sailer V
et al.
. 2018.
Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International Study.
.
Eur Urol.
Mosquera JM
,
Beltran H
,
Park K
,
MacDonald TY
,
Robinson BD
,
Tagawa ST
,
Perner S
,
Bismar TA
,
Erbersdobler A
,
Dhir R
et al.
. 2013.
Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.
.
Neoplasia . (1):1-10.
Mosquera JM
,
Beltran H
,
Park K
,
MacDonald TY
,
Robinson BD
,
Tagawa ST
,
Perner S
,
Bismar TA
,
Erbersdobler A
,
Dhir R
et al.
. 2013.
Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.
.
Neoplasia . (1):1-10.
Terry S
,
El-Sayed IY
,
Destouches D
,
Maillé P
,
Nicolaiew N
,
Ploussard G
,
Semprez F
,
Pimpie C
,
Beltran H
,
Londono-Vallejo A
et al.
. 2015.
CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.
.
Oncotarget. 6(14):11994-2008.
Terry S
,
Maillé P
,
Baaddi H
,
Kheuang L
,
Soyeux P
,
Nicolaiew N
,
Ceraline J
,
Firlej V
,
Beltran H
,
Allory Y
et al.
. 2013.
Cross modulation between the androgen receptor axis and protocadherin-PC in mediating neuroendocrine transdifferentiation and therapeutic resistance of prostate cancer.
.
Neoplasia. 15(7):761-72.
Beltran H
,
Prandi D
,
Mosquera JM
,
Benelli M
,
Puca L
,
Cyrta J
,
Marotz C
,
Giannopolou E
,
Chakravarthi BV
,
Varambally S
et al.
. 2016.
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.
.
Nat Med. 3(22):298-305.
Galletti G
,
Matov A
,
Beltran H
,
Fontugne J
,
Mosquera JMiguel
,
Cheung C
,
MacDonald TY
,
Sung M
,
O'Toole S
,
Kench JG
et al.
. 2014.
ERG induces taxane resistance in castration-resistant prostate cancer.
.
Nat Commun. 5:5548.
Beltran H
,
Park K
,
Tagawa ST
,
Yelensky R
,
Lipson D
,
Frampton G
,
Stephens PJ
,
Cronin MT
,
Nanus DM
,
Mosquera JMiguel
et al.
. 2012.
Identifying cancer mutations in neuroendocrine prostate cancer (NEPC) through massively parallel DNA sequencing of formalin-fixed paraffin-embedded (FFPE) tissue.
.
J Clin Oncol. 30(5_suppl):110.
Pritchard CC
,
Mateo J
,
Walsh MF
,
De Sarkar N
,
Abida W
,
Beltran H
,
Garofalo A
,
Gulati R
,
Carreira S
,
Eeles R
et al.
. 2016.
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
.
N Engl J Med. 375(5):443-53.
Pritchard CC
,
Mateo J
,
Walsh MF
,
De Sarkar N
,
Abida W
,
Beltran H
,
Garofalo A
,
Gulati R
,
Carreira S
,
Eeles R
et al.
. 2016.
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
.
N Engl J Med. 375(5):443-53.
Beltran H
,
Jendrisak A
,
Landers M
,
Mosquera JM
,
Kossai M
,
Louw J
,
Krupa R
,
Graf RP
,
Schreiber NA
,
Nanus DM
et al.
. 2016.
The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer.
.
Clin Cancer Res. 6(22)
Robinson D
,
Van Allen EM
,
Wu Y-M
,
Schultz N
,
Lonigro RJ
,
Mosquera J-M
,
Montgomery B
,
Taplin M-E
,
Pritchard CC
,
Attard G
et al.
. 2015.
Integrative clinical genomics of advanced prostate cancer.
.
Cell. 161(5):1215-28.
Robinson D
,
Van Allen EM
,
Wu Y-M
,
Schultz N
,
Lonigro RJ
,
Mosquera J-M
,
Montgomery B
,
Taplin M-E
,
Pritchard CC
,
Attard G
et al.
. 2015.
Integrative clinical genomics of advanced prostate cancer.
.
Cell. 161(5):1215-28.
Ramnarine VRohan
,
Alshalalfa M
,
Mo F
,
Nabavi N
,
Erho N
,
Takhar M
,
Shukin R
,
Brahmbhatt S
,
Gawronski A
,
Kobelev M
et al.
. 2018.
The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.
.
Gigascience.
Ramnarine VRohan
,
Alshalalfa M
,
Mo F
,
Nabavi N
,
Erho N
,
Takhar M
,
Shukin R
,
Brahmbhatt S
,
Gawronski A
,
Kobelev M
et al.
. 2018.
The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.
.
Gigascience.
Armenia J
,
Wankowicz SAM
,
Liu D
,
Gao J
,
Kundra R
,
Reznik E
,
Chatila WK
,
Chakravarty D
,
G Han C
,
Coleman I
et al.
. 2018.
The long tail of oncogenic drivers in prostate cancer.
.
Nat Genet. 50(5):645-651.
Gillessen S
,
Omlin A
,
Attard G
,
de Bono JS
,
Efstathiou E
,
Fizazi K
,
Halabi S
,
Nelson PS
,
Sartor O
,
Smith MR
et al.
. 2016.
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
.
Ann Oncol.
Gillessen S
,
Omlin A
,
Attard G
,
de Bono JS
,
Efstathiou E
,
Fizazi K
,
Halabi S
,
Nelson PS
,
Sartor O
,
Smith MR
et al.
. 2016.
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
.
Ann Oncol.
Bishop JL
,
Thaper D
,
Vahid S
,
Davies A
,
Ketola K
,
Kuruma H
,
Jama R
,
Nip KMun
,
Angeles A
,
Johnson F
et al.
. 2017.
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer.
.
Cancer Discov. 7(1):54-71.
Beltran H
,
Rickman DS
,
Park K
,
Chae SS
,
Sboner A
,
MacDonald TY
,
Wang Y
,
Sheikh KL
,
Terry S
,
Tagawa ST
et al.
. 2011.
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.
.
Cancer Discovery. 1(6):487-95.
1
(current)
2
next ›
last »